Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Credo Diagnostics Biomedical Pte. Ltd. currently manages 2 pending office actions within the Chemistry & Materials technology area. These actions are both situated within 1 distinct art unit, indicating a concentrated technical focus for the company's current filings. This concentration in 1 art unit suggests that the pending matters are being evaluated against a consistent set of prior art and technical criteria.
The prosecution involves 2 distinct examiners, which provides some diversity in the examination experience despite the single art unit. HENKEL, DANIELLE B is the busiest examiner for the portfolio, currently overseeing 1 pending office action. With 2 distinct examiners for 2 pending actions, each matter is being handled by a different individual, requiring the applicant to adapt to two different examination styles.
Practitioners should note that while the 2 pending office actions are in the same art unit, the use of 2 distinct examiners means that results may vary between applications. HENKEL, DANIELLE B handles 1 of these actions, while the other is managed by a different examiner. This structure in the Chemistry & Materials sector requires a balanced approach that addresses the specific feedback of each examiner while maintaining consistency within the art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| §112 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HENKEL, DANIELLE B | 1 | 56.2% | +23.6% |
| JARRETT, LORE RAMILLANO | 1 | 68.5% | +25.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18234388 | ANALYSIS CARTRIDGE and ANALYSIS METHOD | JARRETT, LORE RAMILLANO | 3d overdue |
| 18614724 | POLYMERASE CHAIN REACTION HEATING DEVICE AND POLYMERASE CHAIN REACTION TEMPERATURE CONTROL SYSTEM | HENKEL, DANIELLE B | — |
| Art Unit | Apps |
|---|---|
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18614724 | POLYMERASE CHAIN REACTION HEATING DEVICE AND POLYMERASE CHAIN REACTION TEMPERATURE CONTROL SYSTEM | HENKEL, DANIELLE B | — | §103 | Non-Final OA | — | Pending | Mar 24, 2024 |
| 18234388 | ANALYSIS CARTRIDGE and ANALYSIS METHOD | JARRETT, LORE RAMILLANO | 1797 | §112 | Final Rejection | 3d overdue | Pending | Aug 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial